Correlation Between Crinetics Pharmaceuticals and Rallybio Corp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Crinetics Pharmaceuticals and Rallybio Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crinetics Pharmaceuticals and Rallybio Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Crinetics Pharmaceuticals and Rallybio Corp, you can compare the effects of market volatilities on Crinetics Pharmaceuticals and Rallybio Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crinetics Pharmaceuticals with a short position of Rallybio Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crinetics Pharmaceuticals and Rallybio Corp.

Diversification Opportunities for Crinetics Pharmaceuticals and Rallybio Corp

-0.53
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Crinetics and Rallybio is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Crinetics Pharmaceuticals and Rallybio Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rallybio Corp and Crinetics Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crinetics Pharmaceuticals are associated (or correlated) with Rallybio Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rallybio Corp has no effect on the direction of Crinetics Pharmaceuticals i.e., Crinetics Pharmaceuticals and Rallybio Corp go up and down completely randomly.

Pair Corralation between Crinetics Pharmaceuticals and Rallybio Corp

Given the investment horizon of 90 days Crinetics Pharmaceuticals is expected to under-perform the Rallybio Corp. But the stock apears to be less risky and, when comparing its historical volatility, Crinetics Pharmaceuticals is 1.22 times less risky than Rallybio Corp. The stock trades about -0.08 of its potential returns per unit of risk. The Rallybio Corp is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  99.00  in Rallybio Corp on August 25, 2024 and sell it today you would earn a total of  3.00  from holding Rallybio Corp or generate 3.03% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy95.65%
ValuesDaily Returns

Crinetics Pharmaceuticals  vs.  Rallybio Corp

 Performance 
       Timeline  
Crinetics Pharmaceuticals 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Crinetics Pharmaceuticals are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Crinetics Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Rallybio Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Rallybio Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unsteady performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Crinetics Pharmaceuticals and Rallybio Corp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Crinetics Pharmaceuticals and Rallybio Corp

The main advantage of trading using opposite Crinetics Pharmaceuticals and Rallybio Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crinetics Pharmaceuticals position performs unexpectedly, Rallybio Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rallybio Corp will offset losses from the drop in Rallybio Corp's long position.
The idea behind Crinetics Pharmaceuticals and Rallybio Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Complementary Tools

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine